Key result
Pre-eclampsia is linked to late-pregnancy cardiovascular index increases above 1.3 versus healthy controls.
Why the study?
The clinical potential of the cardiovascular index (CVI) for monitoring the condition of pregnant women with pre-eclampsia (PE) needed investigation.
Does monitoring the cardiovascular index (CVI) detect the onset or progression of pre-eclampsia in pregnant women compared to healthy controls and those with chronic arterial hypertension?
Cohort (n=264)
Does monitoring the cardiovascular index (CVI) detect the onset or progression of pre-eclampsia in pregnant women compared to healthy controls and those with chronic arterial hypertension?
Answers are grounded in this paper and cite their sources.
Regular self- and clinical monitoring of the cardiovascular index (mean arterial pressure/pulse) in the second half of pregnancy may help identify the onset or progression of pre-eclampsia when values rise above 1.3.
Objective. To study the clinical potential of the cardiovascular index (CVI) for monitoring the condition of pregnant women with pre-eclampsia (PE). Patients and methods. A total of 264 pregnant women were examined. The study group included 67 patients with PE, the comparison group included 35 pregnant women with chronic arterial hypertension (CAH), and the control group included 162 healthy women with uncomplicated pregnancy. The dynamics of changes in blood pressure (BP), pulse and (CVI = mean arterial pressure/pulse) were analyzed. To monitor CVI, a hardware calculation provided by the DETESCO cardiotocograph (model: KTM B Plus) was used, as well as Excel software for self-monitoring of BP and pulse by patients. Results. CVI values in healthy women and patients with CAH ranged from 0.9 to 1.2 and were comparable throughout all three trimesters of pregnancy (p > 0.05). Women with PE had a significant increase in CVI above 1.3 by the end of pregnancy compared to the control group (p = 0.007) and compared to the first trimester in their group (p = 0.0067). Conclusion. Regular calculation of CVI as part of self-monitoring of BP and pulse by patients and medical staff allows for timely detection of an increase in the index, suspicion of the onset, debut, or progression of PE, and decision-making regarding hospitalization and further management of pregnant women. The use of CVI for the prediction and control of obstetric complications is only possible in the second half of pregnancy. This diagnostic/assessment method has been patented (patent for invention No 2846668, patent holder: Kazan State Medical Academy – Branch Campus of the Russian Medical Academy of Continuous Professional Education).
No takes yet. Share an insight, caveat, or question.
Zamaleewa et al. (2025) conducted a cohort in Pre-eclampsia and chronic arterial hypertension in pregnancy (n=264). Cardiovascular index (CVI = mean arterial pressure / pulse) monitoring vs. Healthy uncomplicated pregnancy (n=162) and chronic arterial hypertension (n=35) was evaluated on Dynamics of changes in the cardiovascular index (CVI = mean arterial pressure/pulse) across pregnancy trimesters (p=0.007). Pre-eclampsia was associated with a significant increase in the cardiovascular index above 1.3 by the end of pregnancy compared to healthy controls and first-trimester baseline.
Synapse has enriched 10 related papers. Consider them for comparative context: